Your search returned 73 studies. (Get alerts for new studies):
- Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors
Conditions: Kidney Cancer - Melanoma (Skin) - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer
Conditions: Gastroesophageal Cancer - Gastric Cancer
2 Locations available
- Paclitaxel + Bevacizumab (Avastin®) for the Treatment of Metastatic or Unresectable Angiosarcoma
Conditions: Hemangiosarcoma - Soft Tissue Sarcoma
3 Locations available
- Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas
Conditions: Sarcoma - Soft Tissue Sarcoma - Locally Advanced Sarcoma - Unresectable Sarcoma - Metastatic Sarcoma
1 Location available
- An Open-Label, 2-Cohort, Multicenter, Study of E7080 in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
Conditions: Unresectable Stage III or Stage IV Melanoma
77 Locations available
- Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer
Conditions: Adrenal Cortex Neoplasms
1 Location available
- Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer
Conditions: Cholangiocarcinoma - Pancreatic Cancer
1 Location available
- A Study of IMC-3G3 in Previously Treated Patients With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors
Conditions: Gastrointestinal Stromal Tumor (GIST)
7 Locations available
- Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma
Conditions: Recurrent Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
1 Location available
- Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma
Conditions: Chondrosarcoma - Metastatic Chondrosarcoma
2 Locations available
- Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer
Conditions: Head and Neck Squamous Cell Carcinoma
1 Location available
- Pasireotide, Everolimus and Selective Internal Radioemobilization Therapy for Unresectable Hepatic Metastases
Conditions: Neuroendocrine Tumors
1 Location available
- Dasatinib in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
Conditions: Brain and Central Nervous System Tumors - Liver Cancer - Lymphoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
17 Locations available
- AZD2281 and Carboplatin in Treating Patients With BRCA1/BRCA2-Associated, Hereditary, or Triple Negative Metastatic or Unresectable Breast Cancer or O
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer
1 Location available
- Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma
Conditions: Melanoma
3 Locations available
- Combination of Temozolomide and Sunitinib in Treatment of Patients With Metastatic and Unresectable Malignant Melanoma
Conditions: Melanoma
1 Location available
- Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
Conditions: Liver Cancer
3 Locations available
- Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Melanoma
Conditions: Unresectable Stage III and Stage IV Melanoma
1 Location available
- Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer
3 Locations available
- PII of SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
Conditions: Cholangiocarcinoma - Hepatobiliary Neoplasm - Liver Cancer - Bile Duct Cancer - Cancer of Gallbladder
1 Location available
- A Study of RO5185426 in Patients With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation
Conditions: Neoplasms
5 Locations available
- Sunitinib in Treating Patients With Recurrent or Unresectable Meningioma, Intracranial Hemangiopericytoma, or Intracranial Hemangioblastoma
Conditions: Brain and Central Nervous System Tumors - Neurofibromatosis Type 1 - Neurofibromatosis Type 2 - Precancerous Condition
4 Locations available
- TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma - Liver Cancer - Liver Neoplasm - Primary Liver Cancer
1 Location available
- IMCgp100 in Advanced Unresectable Melanoma
Conditions: Melanoma - Advanced Disease - Unresectable
1 Location available
- A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors
Conditions: Metastatic or Unresectable Solid Tumor Malignancy
3 Locations available
- Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer
Conditions: Pancreatic Cancer
1 Location available
- E7050 in Combination With E7080 in Subjects With Advanced Solid Tumors (Dose Escalation) and in Subjects With Recurrent Glioblastoma or Unresectable S
Conditions: Advanced Solid Tumors
1 Location available
- Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Conditions: Gastroesophageal Junction Adenocarcinoma - Gastric Cancer
15 Locations available
- Irinotecan and ABT-888 in Treating Patients With Metastatic or Unresectable Cancer
Conditions: Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- IMC-A12 and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Conditions: Adult Malignant Fibrous Histiocytoma of Bone - Sarcoma
13 Locations available
- Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial
Conditions: Histologically or Cytologically Confirmed Pancreatic Ca - Unresectable or Borderline Resectable Pancreatic Ca
1 Location available
- TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
1 Location available
- A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer
Conditions: Neoplasms - Neoplasm Metastasis - Pancreatic Cancer
2 Locations available
- VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer
Conditions: Kidney Cancer
174 Locations available
- Proton Therapy for Unresectable Cancer (CA) of Pancreas
Conditions: Pancreatic Cancer
1 Location available
- Effects of Monoclonal Antibody GC1008 in Blood Samples From Patients With Unresectable Locally Advanced or Metastatic Kidney Cancer or Malignant Melan
Conditions: Kidney Cancer - Melanoma (Skin)
1 Location available
- Everolimus and Gemcitabine Hydrochloride in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- Endoscopic Ultrasound (EUS) Guided-Celiac Plexus Neurolysis (CPN) in Unresectable Pancreatic Cancer
Conditions: Pain - Pancreatic Cancer
1 Location available
- A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Pri
Conditions: Metastatic Renal Cell Carcinoma
3 Locations available
- Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least
Conditions: Ewing's Sarcoma - Primitive Neuroectodermal Tumor (PNET) - Askin's Tumor of the Chest Wall - Extraosseous Ewing's Sarcoma (EOE)
3 Locations available
- Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600EBRAF Mutation
Conditions: Melanoma
1 Location available
- Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer
Conditions: Kidney Cancer
7 Locations available
- Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
7 Locations available
- Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Canc
Conditions: Small Intestine Cancer
127 Locations available
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Conditions: Breast Cancer - Colorectal Cancer - Gastric Cancer - Liver Cancer - Melanoma (Skin) - Metastatic Cancer - Ovarian Cancer - Pancreatic Cancer
1 Location available
- Safety Study of Denosumab in Subjects With Recurrent or Unresectable Giant Cell Tumor of Bone
Conditions: Cancer - GCT - Giant Cell Tumor of Bone - Benign GCT
10 Locations available
- TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma
1 Location available
- Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors
Conditions: Gastrointestinal Carcinoid Tumor - Islet Cell Tumor - Metastatic Cancer
1 Location available
- ABT-888 With or Without Mitomycin in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST)
Conditions: Gastrointestinal Stromal Tumor
4 Locations available
- Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Esophagus - Adenocarcinoma of the Gastroesophageal Junction - Diffuse Adenocarcinoma of the Stomach - Intestinal Adenocarcinoma of the Stomach - Mixed Adenocarcinoma of the Stomach - Recurrent Esophageal Cancer - Recurrent Gastric Ca
1 Location available
- A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcino
Conditions: Pancreatic Cancer
1 Location available
- Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma
Conditions: Soft Tissue Sarcoma
2 Locations available
- Combination Chemotherapy and Bevacizumab in Treating Patients With Recurrent, Unresectable, or Metastatic Gastric Cancer, Gastroesophageal Junction Ca
Conditions: Esophageal Cancer - Gastric Cancer
1 Location available
- Sunitinib in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
Conditions: Kidney Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
Conditions: Liver Tumors - Hepatocellular Carcinoma - Hepatoma - Neoplasms
1 Location available
- Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma
Conditions: Unresectable Stage III or IV Melanoma
4 Locations available
- MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.
Conditions: Unresectable or Metastatic Hepatocellular Carcinoma (HCC)
2 Locations available
- Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
Conditions: Adult Liposarcoma - Recurrent Adult Soft Tissue Sarcoma - Stage III Adult Soft Tissue Sarcoma - Stage IV Adult Soft Tissue Sarcoma
2 Locations available
- Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases
Conditions: Colorectal Liver Metastases
1 Location available
- Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia
Conditions: Leukemia - Non-melanomatous Skin Cancer
3 Locations available
- Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer
Conditions: Unresectable or Metastatic Non-small Cell Lung Cancer (NSCLC)
1 Location available
- Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer
Conditions: Locally Advanced (Unresectable) Pancreatic Cancer - Metastatic Pancreatic Cancer
3 Locations available
- A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined
Conditions: Metastatic Colorectal Cancer
23 Locations available
- Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
Conditions: Esophageal Cancer - Gastric Cancer
18 Locations available
- Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
Conditions: Malignant Melanoma
2 Locations available
- IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
Conditions: Cancer of the Liver - Liver Cancer - Hepatoma - Liver Neoplasms - Biliary Cancer
1 Location available
- Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or Transplant
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Localized Unresectable Adult Primary Liver Cancer - Recurrent Adult Primary Liver Cancer
1 Location available
- Biomarkers of RO4929097and Other Drugs in Treating Patients With Metastatic or Unresectable Solid Tumors
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma
Conditions: Conventional Chondrosarcoma
19 Locations available
- Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Me
Conditions: Melanoma
1 Location available
- A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tis
Conditions: Soft Tissue Sarcoma
1 Location available
- Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma
Conditions: Metastatic Soft Tissue Sarcoma - Locally Advanced Soft Tissue Sarcoma - Unresectable Soft Tissue Sarcoma
1 Location available
|